Global Hepatitis B Therapeutics Market Research Report 2023

Report ID: 1972104 | Published Date: Jan 2025 | No. of Page: 80 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Hepatitis B Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Hepatitis B Vaccine
        1.2.3 Anti-viral Drugs
    1.3 Market by Application
        1.3.1 Global Hepatitis B Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Hepatitis B Therapeutics Market Perspective (2017-2028)
    2.2 Hepatitis B Therapeutics Growth Trends by Region
        2.2.1 Hepatitis B Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Hepatitis B Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Hepatitis B Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Hepatitis B Therapeutics Market Dynamics
        2.3.1 Hepatitis B Therapeutics Industry Trends
        2.3.2 Hepatitis B Therapeutics Market Drivers
        2.3.3 Hepatitis B Therapeutics Market Challenges
        2.3.4 Hepatitis B Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Hepatitis B Therapeutics Players by Revenue
        3.1.1 Global Top Hepatitis B Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Hepatitis B Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Hepatitis B Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Hepatitis B Therapeutics Revenue
    3.4 Global Hepatitis B Therapeutics Market Concentration Ratio
        3.4.1 Global Hepatitis B Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Hepatitis B Therapeutics Revenue in 2021
    3.5 Hepatitis B Therapeutics Key Players Head office and Area Served
    3.6 Key Players Hepatitis B Therapeutics Product Solution and Service
    3.7 Date of Enter into Hepatitis B Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Hepatitis B Therapeutics Breakdown Data by Type
    4.1 Global Hepatitis B Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Hepatitis B Therapeutics Forecasted Market Size by Type (2023-2028)
5 Hepatitis B Therapeutics Breakdown Data by Application
    5.1 Global Hepatitis B Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Hepatitis B Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Hepatitis B Therapeutics Market Size (2017-2028)
    6.2 North America Hepatitis B Therapeutics Market Size by Country (2017-2022)
    6.3 North America Hepatitis B Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Hepatitis B Therapeutics Market Size (2017-2028)
    7.2 Europe Hepatitis B Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Hepatitis B Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Hepatitis B Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Hepatitis B Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Hepatitis B Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Hepatitis B Therapeutics Market Size (2017-2028)
    9.2 Latin America Hepatitis B Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Hepatitis B Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Hepatitis B Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Hepatitis B Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Hepatitis B Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 GlaxoSmithKline
        11.1.1 GlaxoSmithKline Company Detail
        11.1.2 GlaxoSmithKline Business Overview
        11.1.3 GlaxoSmithKline Hepatitis B Therapeutics Introduction
        11.1.4 GlaxoSmithKline Revenue in Hepatitis B Therapeutics Business (2017-2022)
        11.1.5 GlaxoSmithKline Recent Development
    11.2 Bristol-Myers Squibb
        11.2.1 Bristol-Myers Squibb Company Detail
        11.2.2 Bristol-Myers Squibb Business Overview
        11.2.3 Bristol-Myers Squibb Hepatitis B Therapeutics Introduction
        11.2.4 Bristol-Myers Squibb Revenue in Hepatitis B Therapeutics Business (2017-2022)
        11.2.5 Bristol-Myers Squibb Recent Development
    11.3 Novira Therapeutics
        11.3.1 Novira Therapeutics Company Detail
        11.3.2 Novira Therapeutics Business Overview
        11.3.3 Novira Therapeutics Hepatitis B Therapeutics Introduction
        11.3.4 Novira Therapeutics Revenue in Hepatitis B Therapeutics Business (2017-2022)
        11.3.5 Novira Therapeutics Recent Development
    11.4 Johnson & Johnson
        11.4.1 Johnson & Johnson Company Detail
        11.4.2 Johnson & Johnson Business Overview
        11.4.3 Johnson & Johnson Hepatitis B Therapeutics Introduction
        11.4.4 Johnson & Johnson Revenue in Hepatitis B Therapeutics Business (2017-2022)
        11.4.5 Johnson & Johnson Recent Development
    11.5 Abivax
        11.5.1 Abivax Company Detail
        11.5.2 Abivax Business Overview
        11.5.3 Abivax Hepatitis B Therapeutics Introduction
        11.5.4 Abivax Revenue in Hepatitis B Therapeutics Business (2017-2022)
        11.5.5 Abivax Recent Development
    11.6 F. Hoffmann- La Roche
        11.6.1 F. Hoffmann- La Roche Company Detail
        11.6.2 F. Hoffmann- La Roche Business Overview
        11.6.3 F. Hoffmann- La Roche Hepatitis B Therapeutics Introduction
        11.6.4 F. Hoffmann- La Roche Revenue in Hepatitis B Therapeutics Business (2017-2022)
        11.6.5 F. Hoffmann- La Roche Recent Development
    11.7 Novartis
        11.7.1 Novartis Company Detail
        11.7.2 Novartis Business Overview
        11.7.3 Novartis Hepatitis B Therapeutics Introduction
        11.7.4 Novartis Revenue in Hepatitis B Therapeutics Business (2017-2022)
        11.7.5 Novartis Recent Development
    11.8 Merck
        11.8.1 Merck Company Detail
        11.8.2 Merck Business Overview
        11.8.3 Merck Hepatitis B Therapeutics Introduction
        11.8.4 Merck Revenue in Hepatitis B Therapeutics Business (2017-2022)
        11.8.5 Merck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Hepatitis B Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Hepatitis B Vaccine
    Table 3. Key Players of Anti-viral Drugs
    Table 4. Global Hepatitis B Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Hepatitis B Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Hepatitis B Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Hepatitis B Therapeutics Market Share by Region (2017-2022)
    Table 8. Global Hepatitis B Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Hepatitis B Therapeutics Market Share by Region (2023-2028)
    Table 10. Hepatitis B Therapeutics Market Trends
    Table 11. Hepatitis B Therapeutics Market Drivers
    Table 12. Hepatitis B Therapeutics Market Challenges
    Table 13. Hepatitis B Therapeutics Market Restraints
    Table 14. Global Hepatitis B Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Hepatitis B Therapeutics Market Share by Players (2017-2022)
    Table 16. Global Top Hepatitis B Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B Therapeutics as of 2021)
    Table 17. Ranking of Global Top Hepatitis B Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Hepatitis B Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Hepatitis B Therapeutics Product Solution and Service
    Table 21. Date of Enter into Hepatitis B Therapeutics Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Hepatitis B Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Hepatitis B Therapeutics Revenue Market Share by Type (2017-2022)
    Table 25. Global Hepatitis B Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Hepatitis B Therapeutics Revenue Market Share by Type (2023-2028)
    Table 27. Global Hepatitis B Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Hepatitis B Therapeutics Revenue Market Share by Application (2017-2022)
    Table 29. Global Hepatitis B Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Hepatitis B Therapeutics Revenue Market Share by Application (2023-2028)
    Table 31. North America Hepatitis B Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Hepatitis B Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Hepatitis B Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Hepatitis B Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Hepatitis B Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Hepatitis B Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Hepatitis B Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Hepatitis B Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Hepatitis B Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Hepatitis B Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 41. GlaxoSmithKline Company Detail
    Table 42. GlaxoSmithKline Business Overview
    Table 43. GlaxoSmithKline Hepatitis B Therapeutics Product
    Table 44. GlaxoSmithKline Revenue in Hepatitis B Therapeutics Business (2017-2022) & (US$ Million)
    Table 45. GlaxoSmithKline Recent Development
    Table 46. Bristol-Myers Squibb Company Detail
    Table 47. Bristol-Myers Squibb Business Overview
    Table 48. Bristol-Myers Squibb Hepatitis B Therapeutics Product
    Table 49. Bristol-Myers Squibb Revenue in Hepatitis B Therapeutics Business (2017-2022) & (US$ Million)
    Table 50. Bristol-Myers Squibb Recent Development
    Table 51. Novira Therapeutics Company Detail
    Table 52. Novira Therapeutics Business Overview
    Table 53. Novira Therapeutics Hepatitis B Therapeutics Product
    Table 54. Novira Therapeutics Revenue in Hepatitis B Therapeutics Business (2017-2022) & (US$ Million)
    Table 55. Novira Therapeutics Recent Development
    Table 56. Johnson & Johnson Company Detail
    Table 57. Johnson & Johnson Business Overview
    Table 58. Johnson & Johnson Hepatitis B Therapeutics Product
    Table 59. Johnson & Johnson Revenue in Hepatitis B Therapeutics Business (2017-2022) & (US$ Million)
    Table 60. Johnson & Johnson Recent Development
    Table 61. Abivax Company Detail
    Table 62. Abivax Business Overview
    Table 63. Abivax Hepatitis B Therapeutics Product
    Table 64. Abivax Revenue in Hepatitis B Therapeutics Business (2017-2022) & (US$ Million)
    Table 65. Abivax Recent Development
    Table 66. F. Hoffmann- La Roche Company Detail
    Table 67. F. Hoffmann- La Roche Business Overview
    Table 68. F. Hoffmann- La Roche Hepatitis B Therapeutics Product
    Table 69. F. Hoffmann- La Roche Revenue in Hepatitis B Therapeutics Business (2017-2022) & (US$ Million)
    Table 70. F. Hoffmann- La Roche Recent Development
    Table 71. Novartis Company Detail
    Table 72. Novartis Business Overview
    Table 73. Novartis Hepatitis B Therapeutics Product
    Table 74. Novartis Revenue in Hepatitis B Therapeutics Business (2017-2022) & (US$ Million)
    Table 75. Novartis Recent Development
    Table 76. Merck Company Detail
    Table 77. Merck Business Overview
    Table 78. Merck Hepatitis B Therapeutics Product
    Table 79. Merck Revenue in Hepatitis B Therapeutics Business (2017-2022) & (US$ Million)
    Table 80. Merck Recent Development
    Table 81. Research Programs/Design for This Report
    Table 82. Key Data Information from Secondary Sources
    Table 83. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Hepatitis B Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Hepatitis B Vaccine Features
    Figure 3. Anti-viral Drugs Features
    Figure 4. Global Hepatitis B Therapeutics Market Share by Application in 2021 & 2028
    Figure 5. Hospital Pharmacies Case Studies
    Figure 6. Retail Pharmacies Case Studies
    Figure 7. Online Pharmacies Case Studies
    Figure 8. Hepatitis B Therapeutics Report Years Considered
    Figure 9. Global Hepatitis B Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Hepatitis B Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Hepatitis B Therapeutics Market Share by Region: 2021 VS 2028
    Figure 12. Global Hepatitis B Therapeutics Market Share by Players in 2021
    Figure 13. Global Top Hepatitis B Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B Therapeutics as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Hepatitis B Therapeutics Revenue in 2021
    Figure 15. North America Hepatitis B Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Hepatitis B Therapeutics Market Share by Country (2017-2028)
    Figure 17. United States Hepatitis B Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Hepatitis B Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Hepatitis B Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Hepatitis B Therapeutics Market Share by Country (2017-2028)
    Figure 21. Germany Hepatitis B Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Hepatitis B Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Hepatitis B Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Hepatitis B Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Hepatitis B Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Hepatitis B Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Hepatitis B Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Hepatitis B Therapeutics Market Share by Region (2017-2028)
    Figure 29. China Hepatitis B Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Hepatitis B Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Hepatitis B Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Hepatitis B Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Hepatitis B Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Hepatitis B Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Hepatitis B Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Hepatitis B Therapeutics Market Share by Country (2017-2028)
    Figure 37. Mexico Hepatitis B Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Hepatitis B Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Hepatitis B Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Hepatitis B Therapeutics Market Share by Country (2017-2028)
    Figure 41. Turkey Hepatitis B Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Hepatitis B Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. GlaxoSmithKline Revenue Growth Rate in Hepatitis B Therapeutics Business (2017-2022)
    Figure 44. Bristol-Myers Squibb Revenue Growth Rate in Hepatitis B Therapeutics Business (2017-2022)
    Figure 45. Novira Therapeutics Revenue Growth Rate in Hepatitis B Therapeutics Business (2017-2022)
    Figure 46. Johnson & Johnson Revenue Growth Rate in Hepatitis B Therapeutics Business (2017-2022)
    Figure 47. Abivax Revenue Growth Rate in Hepatitis B Therapeutics Business (2017-2022)
    Figure 48. F. Hoffmann- La Roche Revenue Growth Rate in Hepatitis B Therapeutics Business (2017-2022)
    Figure 49. Novartis Revenue Growth Rate in Hepatitis B Therapeutics Business (2017-2022)
    Figure 50. Merck Revenue Growth Rate in Hepatitis B Therapeutics Business (2017-2022)
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
    Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GlaxoSmithKline
Bristol-Myers Squibb
Novira Therapeutics
Johnson & Johnson
Abivax
F. Hoffmann- La Roche
Novartis
Merck
Frequently Asked Questions
Hepatitis B Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Hepatitis B Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Hepatitis B Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Gas Shutoff Devices

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More